Outlook Therapeutics
OTLK
$8.92
Share price
-1.98%
Change (1 day)
662.39%
Change (1 year)
Categories
Earnings for Outlook Therapeutics (OTLK)
Earnings in 2023 (TTM): -$51.5 M
According to Outlook Therapeutics 's latest financial reports the company's current earnings (TTM) are -$51.5 M. In 2022 the company made an earning of -$70.25 M a decrease over its 2021 earnings that were of -$53.17 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Outlook Therapeutics from 2015 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$51.5 M | -26.7% |
| 2022 | -$70.25 M | 32.13% |
| 2021 | -$53.17 M | 46.21% |
| 2020 | -$36.37 M | -18.82% |
| 2019 | -$44.8 M | 16.62% |
| 2018 | -$38.42 M | 57.88% |
| 2017 | -$24.33 M | -56.17% |
| 2016 | -$55.51 M | -9.26% |
| 2015 | -$61.18 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | -$19.09 M | -62.94% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | -$73.07 M | 41.88% | 🇬🇧 UK |
 Novavax NVAX | -$0.53 B | 926.52% | 🇺🇸 USA |
 Novocure
NVCR | -$0.19 B | 265.90% | Jersey |